Clinical Trial

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

Name: Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer — clinical trial record (NCT07189455)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The main objective is to compare ZG006 with Investigator-Selected Chemotherapy on prolonging overall survival (OS).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-16.

Status change: Not Yet Recruiting → Recruiting 2025-12-30

Trial Details

NCT Number	NCT07189455
Lead Sponsor	Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Conditions	Small-cell Lung Cancer
Enrollment	420 participants
Start Date	2025-12-12
Primary Completion	2028-10 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-05